How does the FTC PBM investigation affect the industry?

The FTC launched its investigation in June 2022, issuing 6(b) orders to the Big 3 PBMs. The interim report found significant vertical integration concerns and rebate practices that may disadvantage independent pharmacies and inflate costs. Potential outcomes include consent decrees, new rulemaking on rebate transparency, or referral to DOJ.